Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Da Costa AABA"'
Autor:
Ravindranathan R; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., Somuncu O; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., da Costa AABA; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., Mukkavalli S; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., Lamarre BP; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., Nguyen H; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., Grochala C; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., Jiao Y; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., Liu J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., Kochupurakkal B; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., Parmar K; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., Shapiro GI; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., D'Andrea AD; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Nov 19; Vol. 121 (47), pp. e2413954121. Date of Electronic Publication: 2024 Nov 15.
Autor:
da Costa AABA; Department of Medical Oncology, A.C. Camargo Cancer Center, 211 Professor Antonio Prudente Street, Liberdade, Sao Paulo, SP 01509-900, Brazil. Electronic address: alexandre.dacosta@accamargo.org.br., Souza RP; Department of Medical Oncology, A.C. Camargo Cancer Center, 211 Professor Antonio Prudente Street, Liberdade, Sao Paulo, SP 01509-900, Brazil., Pandolfi NC; Department of Medical Oncology, A.C. Camargo Cancer Center, 211 Professor Antonio Prudente Street, Liberdade, Sao Paulo, SP 01509-900, Brazil., de Souza Castro F; Department of Medical Oncology, A.C. Camargo Cancer Center, 211 Professor Antonio Prudente Street, Liberdade, Sao Paulo, SP 01509-900, Brazil., Baiocchi G; Department of Gynecology Oncology, A.C. Camargo Cancer Center, 211 Professor Antonio Prudente Street, Liberdade, Sao Paulo, SP 01509-900, Brazil., Guimarães APG; Department of Medical Oncology, A.C. Camargo Cancer Center, 211 Professor Antonio Prudente Street, Liberdade, Sao Paulo, SP 01509-900, Brazil.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2024 Oct; Vol. 189, pp. 109-110. Date of Electronic Publication: 2024 Jul 30.
Autor:
Konstantinopoulos PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Cheng SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lee EK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., da Costa AABA; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA., Gulhan D; Department of Biomedical Informatics and Ludwig Center at Harvard, Harvard Medical School, Boston, MA., Wahner Hendrickson AE; Department of Medical Oncology, Mayo Clinic, Rochester, MN., Kochupurakkal B; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA., Kolin DL; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Kohn EC; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD., Liu JF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Penson RT; Department of Medical Oncology, Massachusetts General Hospital, Boston, MA., Stover EH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Curtis J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Sawyer H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Polak M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Chowdhury D; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA., D'Andrea AD; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA., Färkkilä A; Research Program in Systems Oncology, FIMM and HiLife, University of Helsinki, Helsinki, Finland., Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Matulonis UA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Apr; Vol. 8, pp. e2300635.
Autor:
O'Mahony DG; Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, 2371, Cyprus.; Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, 2371, Cyprus., Ramus SJ; School of Clinical Medicine, University of New South Wales Medicine and Health, University of New South Wales Sydney, Sydney, NSW, 2052, Australia.; Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales Sydney, Sydney, NSW, 2052, Australia., Southey MC; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, 3168, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, 3010, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, 3004, Australia., Meagher NS; School of Clinical Medicine, University of New South Wales Medicine and Health, University of New South Wales Sydney, Sydney, NSW, 2052, Australia.; Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales Sydney, Sydney, NSW, 2052, Australia.; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, NSW, Australia., Hadjisavvas A; Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, 2371, Cyprus., John EM; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94304, USA., Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany., Imyanitov EN; N.N. Petrov Institute of Oncology, St. Petersburg, 197758, Russia., Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, M5G 1×5, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, M5S 1A8, Canada., Sharma P; Department of Internal Medicine, Division of Medical Oncology, University of Kansas Medical Center, Westwood, KS, 66205, USA., Daly MB; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Hake CR; Waukesha Memorial Hospital-Pro Health Care, Waukesha, WI, 53188, USA., Weitzel JN; The University of Kansas Cancer Center, Kansas City, MO, 66160, USA., Jakubowska A; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, 171-252, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, 171-252, Poland., Godwin AK; Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS, 66160, USA., Arason A; Department of Pathology, Landspitali University Hospital, Reykjavik, 101, Iceland.; BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, 101, Iceland., Bane A; Department of Pathology & Molecular Medicine, Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON, L8V 1C3, Canada., Simard J; Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Québec City, QC, G1V 4G2, Canada., Soucy P; Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Québec City, QC, G1V 4G2, Canada., Caligo MA; SOD Genetica Molecolare, University Hospital, Pisa, 56126, Italy., Mai PL; Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA., Claes KBM; Centre for Medical Genetics, Ghent University, Gent, 9000, Belgium., Teixeira MR; Department of Laboratory Genetics, Portuguese Oncology Institute of Porto (IPO Porto)/Comprehensive Cancer Center, Porto, 4200-072, Portugal.; School of Medicine and Biomedical Sciences Institute (ICBAS), University of Porto, Porto, 4050-013, Portugal., Chung WK; Departments of Pediatrics and Medicine, Columbia University, New York, NY, 10032, USA., Lazaro C; Hereditary Cancer Program, ONCOBELL-IDIBELL-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, 08908, Spain., Hulick PJ; Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, 60201, USA.; The University of Chicago Pritzker School of Medicine, Chicago, IL, 60637, USA., Toland AE; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, 43210, USA., Pedersen IS; Molecular Diagnostics, Aalborg University Hospital, Aalborg, 9000, Denmark.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, 9000, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, 9000, Denmark., Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA., Vega A; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, 28029, Spain.; Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, 15706, Spain.; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, 15706, Spain., de la Hoya M; Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, 28040, Spain., Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, 00290, Finland., Dhawan M; Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, CA, 94143-1714, USA., Zampiga V; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Danesi R; Romagna Cancer Registry, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, 47014, Italy., Varesco L; Unit of Hereditary Cancer, IRCCS Ospedale Policlinico San Martino, Genoa, 16132, Italy., Gismondi V; Unit of Hereditary Cancer, IRCCS Ospedale Policlinico San Martino, Genoa, 16132, Italy., Vellone VG; Unit of Pathology, IRCCS Ospedale Policlinico San Martino, Genoa, 16132, Italy., James PA; Department of Gynecology and Obstetrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, 14049-900, Brazil., Janavicius R; Faculty of Medicine, Institute of Biomedical Sciences, Department of Human and Medical Genetics, Vilnius University, Vilnius, LT-03101, Lithuania.; State Research Institute Centre for Innovative Medicine, Vilnius, 8410, Lithuania., Nikitina-Zake L; Latvian Biomedical Research and Study Centre, Riga, LV-1067, Latvia., Nielsen FC; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, DK-2100, Denmark., van Overeem Hansen T; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, DK-2100, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, , University of Copenhagen, Copenhagen, 2200, Denmark., Pejovic T; Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA., Borg A; Department of Oncology, Lund University and Skåne University Hospital, Lund, 222 41, Sweden., Rantala J; Clinical Genetics, Karolinska Institutet, Stockholm, 171 76, Sweden., Offit K; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Montagna M; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, 35128, Italy., Nathanson KL; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, 19066, USA., Domchek SM; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, 19066, USA., Osorio A; Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, 28029, Spain.; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, 28029, Spain.; Genetics Service, Fundación Jiménez Díaz, Madrid, 28040, Spain., García MJ; Computational Oncology Group, Structural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, 28029, Spain., Karlan BY; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, 90095, USA., De Fazio A; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, NSW, Australia.; Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, NSW, 2145, Australia.; The University of Sydney, Sydney, NSW, 2145, Australia., Bowtell D; Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, 3000, Australia., McGuffog L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK., Leslie G; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK., Parsons MT; Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia., Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, 30625, Germany., Speith LM; Gynaecology Research Unit, Hannover Medical School, Hannover, 30625, Germany., Dos Santos ES; Service de Génétique, Institut Curie, Paris, 75005, France.; Oncology Center, Hospital Sirio-Libanes, São Paulo, 01308-050, Brazil.; Department of Clinical Oncology, A.C.Camargo Cancer Center, São Paulo, 1509900, Brazil., da Costa AABA; Department of Clinical Oncology, A.C.Camargo Cancer Center, São Paulo, 1509900, Brazil.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, 2215, USA., Radice P; Unit of Preventive Medicine: Molecular Bases of Genetic Risk, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, 20133, Italy., Peterlongo P; Genome Diagnostics Program, IFOM ETS - the AIRC Institute of Molecular Oncology, Milan, 20139, Italy., Papi L; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics Unit, University of Florence, Florence, 27571, Italy., Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, 04107, Germany.; LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, 04103, Germany., Hahnen E; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, 50937, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, 50937, Germany., Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, 50937, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, 50937, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, 50931, Germany., Wappenschmidt B; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, 50937, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, 50937, Germany., Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK., Tischkowitz M; Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, QC, H4A 3J1, Canada.; Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, CB2 0QQ, UK., Singer CF; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria., Tan YY; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria., Whittemore AS; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, 94305, USA., Sieh W; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Brenton JD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, CB2 0RE, UK., Yannoukakos D; Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, 15310, Greece., Fostira F; Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, 15310, Greece., Konstantopoulou I; Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, 15310, Greece., Soukupova J; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, 12000, Czech Republic., Vocka M; Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, 12000, Czech Republic., Chenevix-Trench G; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia., Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK., Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK., Goldgar DE; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, 84112, USA., Spurdle AB; Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia., Michailidou K; Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, 2371, Cyprus. kyriakimi@cing.ac.cy.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK. kyriakimi@cing.ac.cy.
Publikováno v:
British journal of cancer [Br J Cancer] 2023 Jun; Vol. 128 (12), pp. 2283-2294. Date of Electronic Publication: 2023 Apr 19.
Autor:
Nunes RL; Department of Gynecologic Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil., Teixeira FR; Department of Gynecologic Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil., Diniz TP; Department of Gynecologic Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil., Faloppa CC; Department of Gynecologic Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil., Mantoan H; Department of Gynecologic Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil., da Costa AABA; Department of Medical Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil., Baiocchi G; Department of Gynecologic Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil. glbaiocchi@hotmail.com.
Publikováno v:
Journal of gynecologic oncology [J Gynecol Oncol] 2023 May; Vol. 34 (3), pp. e31. Date of Electronic Publication: 2023 Jan 20.
Autor:
da Costa AABA; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chowdhury D; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., D'Andrea AD; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Alan_Dandrea@dfci.harvard.edu.; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA, USA. Alan_Dandrea@dfci.harvard.edu., Konstantinopoulos PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Panagiotis_konstantinopoulos@dfci.harvard.edu.
Publikováno v:
Nature reviews. Drug discovery [Nat Rev Drug Discov] 2023 Jan; Vol. 22 (1), pp. 38-58. Date of Electronic Publication: 2022 Oct 06.
Autor:
Ruano APC; International Research Center, A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil., Gadelha Guimarães AP; Medical Oncology Department, A.C.Camargo Cancer Center, São Paulo 01525-010, Brazil., Braun AC; International Research Center, A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil., Flores BCTCP; International Research Center, A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil., Tariki MS; Medical Oncology Department, A.C.Camargo Cancer Center, São Paulo 01525-010, Brazil., Abdallah EA; International Research Center, A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil., Torres JA; International Research Center, A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil., Nunes DN; International Research Center, A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil., Tirapelli B; Medical Oncology Department, A.C.Camargo Cancer Center, São Paulo 01525-010, Brazil., de Lima VCC; Medical Oncology Department, A.C.Camargo Cancer Center, São Paulo 01525-010, Brazil., Fanelli MF; Núcleo de Pesquisa e Ensino da Rede São Camilo, São Paulo 04014-002, Brazil., Colombo PE; Department of Surgical Oncology, Institut du Cancer de Montpellier, ICM-Val d'Aurelle, 34090 Montpellier, France., da Costa AABA; Medical Oncology Department, A.C.Camargo Cancer Center, São Paulo 01525-010, Brazil., Alix-Panabières C; Laboratory of Rare Human Circulating Cells (LCCRH), Department University Medical Centre of Montpellier, 34295 Montpellier, France.; CREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, 34000 Montpellier, France., Chinen LTD; Núcleo de Pesquisa e Ensino da Rede São Camilo, São Paulo 04014-002, Brazil.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2022 Nov 24; Vol. 23 (23). Date of Electronic Publication: 2022 Nov 24.
Autor:
Baiocchi G; Department of Gynecologic Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil., de Freitas RR; Department of Surgical Oncology, Sao Francisco de Assis Hospital, Jacarei, Brazil., Bovolim G; Department of Anatomic Pathology, AC Camargo Cancer Center, Sao Paulo, Brazil., Badiglian-Filho L; Department of Gynecologic Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil., da Costa AABA; Department of Medical Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil., De Brot L; Department of Anatomic Pathology, AC Camargo Cancer Center, Sao Paulo, Brazil.
Publikováno v:
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2022 Apr; Vol. 157 (1), pp. 102-109. Date of Electronic Publication: 2021 Aug 03.
Autor:
LaFargue CJ; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Handley KF; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Fleming ND; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Nick AM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Chelariu-Raicu A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Fellman B; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Castellano T; Department of Gynecologic Oncology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America., Ogasawara A; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan., Hom-Tedla M; Department of Gynecologic Oncology, University of Southern California, Los Angeles, CA, United States of America., Blake EA; Department of Gynecologic Oncology, University of Southern California, Los Angeles, CA, United States of America., da Costa AABA; Department of Medical Oncology, A.C. Camargo Cancer Center, Sao Paulo, Brazil., Crim AK; Department of Gynecologic Oncology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America., Rauh-Hain A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Coleman RL; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Matsuo K; Department of Gynecologic Oncology, University of Southern California, Los Angeles, CA, United States of America., Baiocchi G; Department of Gynecologic Oncology, A.C. Camargo Cancer Center, Sao Paulo, Brazil., Hasegawa K; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan., Moore K; Department of Gynecologic Oncology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America., Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. Electronic address: asood@mdanderson.org.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2022 Apr; Vol. 165 (1), pp. 82-89. Date of Electronic Publication: 2022 Feb 23.
Autor:
Pinto PJJ; Department of Radiation Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil., Chen MJ; Department of Radiation Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil., Santos Neto E; Department of Radiation Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil., Faloppa CC; Department of Gynecologic Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil., De Brot L; Department of Pathology, AC Camargo Cancer Center, São Paulo, Brazil., Guimaraes APG; Department of Medical Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil., da Costa AABA; Department of Medical Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil., Baiocchi G; Department of Gynecologic Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil glauco.baiocchi@accamargo.org.br.
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2022 Mar; Vol. 32 (3), pp. 239-245.